Emergency Medicine Doctors in Gadsden, AL Accepting Medicare

10 Emergency Medicine doctors found. Showing 1 - 10

Malachy Ikechukwu Ijemere, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 S 3rd St, Gadsden, AL 35901 Phone: 904-805-1300    Fax: 904-805-1302

Dr. Cyrus Shawn Vepa, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 S 3rd St, Gadsden, AL 35901 Phone: 904-805-1300    Fax: 904-805-1302

Dr. Christopher G Endfinger, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1007 Goodyear Ave, Gadsden, AL 35903 Phone: 256-494-4000

Greg R Smith, NP Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 S 3rd St, Gadsden, AL 35901 Phone: 256-543-5390

Sampson Ogbuchi, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 S 3rd St, Gadsden, AL 35901 Phone: 386-274-7800    Fax: 386-274-7800

Radwan Mallah, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 S 3rd St, Gadsden, AL 35901 Phone: 256-543-5200

Dr. Linda Jean Jones, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1007 Goodyear Ave, Gadsden, AL 35903 Phone: 256-494-4000

Kathryn Peilen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 S 3rd St, Gadsden, AL 35901 Phone: 904-805-1300    Fax: 904-805-1302

Dr. Richard A Vann, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1007 Goodyear Ave, Gadsden, AL 35903 Phone: 256-494-4100

Mr. James D Cade Henderson, CRNP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1007 Goodyear Ave, Gadsden, AL 35903 Phone: 256-494-4000

News Archive

CytRx commences tamibarotene Phase 2b clinical trial in NSCLC

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it is initiating a multicenter Phase 2b clinical trial with its oncology drug candidate tamibarotene in combination with chemotherapeutical agents for the treatment of patients with advanced non-small-cell lung cancer (NSCLC).

Scientists investigate how fungus interacts with bacteria to trigger Crohn's disease

Scientists have known that bacteria in the gut, along with environmental and genetic factors, contribute to the debilitating intestinal ailment of Crohn's disease.

New depression treatment from Magstim to be exhibited at Royal College of Psychiatry International Congress 2015

The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, will be showing its Magstim Rapid2 Therapy System at the Royal College of Psychiatry International Congress 2015 in Birmingham, UK, 29th June-2nd July.

Centocor Ortho Biotech, AVEO sign license deal to develop, commercialize RON-targeted antibodies

AVEO Pharmaceuticals, Inc. today announced it has entered into an exclusive license agreement with Centocor Ortho Biotech Inc. for the worldwide development and commercialization of AVEO's internally-discovered antibodies targeting the RON receptor.

Proxsys Rx provides end-to-end solution to help hospitals comply with all 340B program

Proxsys Rx, the nation's largest Integrated Outpatient Pharmacy Provider (IOPP), now provides an end-to-end solution to hospitals to help them comply with all aspects of the 340B program. Under the federally mandated 340B program, drug makers must provide eligible organizations with certain prescription drugs at significantly reduced prices.

Read more Medical News

› Verified 9 days ago